BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32054478)

  • 1. The gender-related variability in the pharmacokinetics and antiplasmodial activity of naphthoquine in rodents.
    Xie Y; Liu H; Sun Y; Xing J
    Malar J; 2020 Feb; 19(1):71. PubMed ID: 32054478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Gastric pH on the Pharmacokinetics-pharmacodynamics of Naphthoquine in Rodents, as well as in Human Predicted Using a PBPK Model.
    Xie Y; Liu H; Chen X; Xing J
    Curr Drug Metab; 2021; 22(5):363-371. PubMed ID: 33511926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.
    Liu H; Zhou H; Cai T; Yang A; Zang M; Xing J
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the component in Artemisia annua L. leading to enhanced antiplasmodial potency of artemisinin via regulation of its metabolism.
    Cai TY; Zhang YR; Ji JB; Xing J
    J Ethnopharmacol; 2017 Jul; 207():86-91. PubMed ID: 28642094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite identification of the antimalarial naphthoquine using liquid chromatography-tandem high-resolution mass spectrometry in combination with multiple data-mining tools.
    Sun Y; Wang S; Ji J; Zhai G; Xing J
    Biomed Chromatogr; 2018 Jun; 32(6):e4207. PubMed ID: 29430676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
    Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
    Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.
    Batty KT; Salman S; Moore BR; Benjamin J; Lee ST; Page-Sharp M; Pitus N; Ilett KF; Mueller I; Hombhanje FW; Siba P; Davis TM
    Antimicrob Agents Chemother; 2012 May; 56(5):2472-84. PubMed ID: 22330923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chrysosplenetin on the pharmacokinetics and anti-malarial efficacy of artemisinin against Plasmodium berghei as well as in vitro CYP450 enzymatic activities in rat liver microsome.
    Wei S; Ji H; Yang B; Ma L; Bei Z; Li X; Dang H; Yang X; Liu C; Wu X; Chen J
    Malar J; 2015 Nov; 14():432. PubMed ID: 26537009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of malaria-induced alteration of metabolism on piperaquine disposition in Plasmodium yoelii infected mice and predicted in malaria patients.
    Xie Y; Zhang Y; Lin F; Chen X; Xing J
    Int J Antimicrob Agents; 2024 Jul; 64(1):107209. PubMed ID: 38761871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo.
    Ji S; Liu M; Galon EM; Rizk MA; Tuvshintulga B; Li J; Zafar I; Hasegawa Y; Iguchi A; Yokoyama N; Xuan X
    Parasit Vectors; 2022 Jan; 15(1):10. PubMed ID: 34991686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model.
    Nurul Aiezzah Z; Noor E; Hasidah MS
    Trop Biomed; 2010 Dec; 27(3):624-31. PubMed ID: 21399604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: an approach by enhanced bioavailability.
    Dwivedi P; Khatik R; Chaturvedi P; Khandelwal K; Taneja I; Raju KS; Dwivedi H; Singh SK; Gupta PK; Shukla P; Tripathi P; Singh S; Tripathi R; Wahajuddin ; Paliwal SK; Dwivedi AK; Mishra PR
    Colloids Surf B Biointerfaces; 2015 Feb; 126():467-75. PubMed ID: 25616971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
    Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
    Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections.
    Li Q; O'Neil M; Xie L; Caridha D; Zeng Q; Zhang J; Pybus B; Hickman M; Melendez V
    Malar J; 2014 Apr; 13():141. PubMed ID: 24731238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro biotransformation, in vivo efficacy and pharmacokinetics of antimalarial chalcones.
    Gutteridge CE; Thota DS; Curtis SM; Kozar MP; Li Q; Xie L; Zhang J; Melendez V; Asher CO; Luong TT; Gerena L; Nichols DA; Montip G
    Pharmacology; 2011; 87(1-2):96-104. PubMed ID: 21282967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Zhou S; Kestell P; Tingle MD; Paxton JW
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiplasmodial effect of the extracts and formulated capsules of Phyllanthus amarus on Plasmodium yoelii infection in mice.
    Ajala TO; Igwilo CI; Oreagba IA; Odeku OA
    Asian Pac J Trop Med; 2011 Apr; 4(4):283-7. PubMed ID: 21771471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic interaction between Khaya grandifoliola (WELW) CDC stem bark extract and two anti-malarial drugs in mice.
    Ijarotimi SO; Agbedahunsi JM; Onyeji CO; Adewunmi CO
    Afr J Tradit Complement Altern Med; 2010; 7(4):370-6. PubMed ID: 21731168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.